Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 2
2006 2
2007 2
2008 3
2009 1
2012 1
2013 1
2014 1
2015 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
GB virus C: insights into co-infection.
Berzsenyi MD, Bowden DS, Roberts SK. Berzsenyi MD, et al. Among authors: bowden ds. J Clin Virol. 2005 Aug;33(4):257-66. doi: 10.1016/j.jcv.2005.04.002. J Clin Virol. 2005. PMID: 15922655 Review.
Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants.
Thompson AJ, Jackson K, Bonanzinga S, Hall SAL, Hume S, Burns GS, Sundararajan V, Ratnam D, Levy MT, Lubel J, Nicoll AJ, Strasser SI, Sievert W, Desmond PV, Ngu MC, Sinclair M, Meredith C, Matthews G, Revill PA, Littlejohn M, Bowden DS, Canchola JA, Torres J, Siew P, Lau J, La Brot B, Kuchta A, Visvanathan K. Thompson AJ, et al. Among authors: bowden ds. Hepatol Commun. 2023 Jul 17;7(8):e0188. doi: 10.1097/HC9.0000000000000188. eCollection 2023 Aug 1. Hepatol Commun. 2023. PMID: 37459199 Free PMC article. Clinical Trial.
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels.
Hall SAL, Burns GS, Anagnostou D, Vogrin S, Sundararajan V, Ratnam D, Levy MT, Lubel JS, Nicoll AJ, Strasser SI, Sievert W, Desmond PV, Ngu MC, Angus P, Sinclair M, Meredith C, Matthews G, Revill PA, Jackson K, Littlejohn M, Bowden DS, Locarnini SA, Visvanathan K, Thompson AJ. Hall SAL, et al. Among authors: bowden ds. Aliment Pharmacol Ther. 2022 Jul;56(2):310-320. doi: 10.1111/apt.16968. Epub 2022 May 6. Aliment Pharmacol Ther. 2022. PMID: 35521992
A multistate outbreak of hepatitis A associated with semidried tomatoes in Australia, 2009.
Donnan EJ, Fielding JE, Gregory JE, Lalor K, Rowe S, Goldsmith P, Antoniou M, Fullerton KE, Knope K, Copland JG, Bowden DS, Tracy SL, Hogg GG, Tan A, Adamopoulos J, Gaston J, Vally H. Donnan EJ, et al. Among authors: bowden ds. Clin Infect Dis. 2012 Mar;54(6):775-81. doi: 10.1093/cid/cir949. Epub 2012 Jan 11. Clin Infect Dis. 2012. PMID: 22238166
Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody Microarrays.
Rahman W, Tu T, Budzinska M, Huang P, Belov L, Chrisp JS, Christopherson RI, Warner FJ, Bowden DS, Thompson AJ, Bowen DG, Strasser SI, Koorey D, Sharland AF, Yang JY, McCaughan GW, Shackel NA. Rahman W, et al. Among authors: bowden ds. Transplantation. 2015 Sep;99(9):e120-6. doi: 10.1097/TP.0000000000000617. Transplantation. 2015. PMID: 25706280
20 results